Description

Retatrutide

10MG VIAL

Retatrutide functions as a triple agonist for GGG, targeting GLP-1 and GIP receptors like traditional GLP-1 agonists while additionally activating the glucagon receptor. This unique interaction boosts glucagon production, facilitating the breakdown of stored fats and glycogen, thereby elevating basal metabolism for sustained fat loss. Its effects on GLP-1 and GIP receptors also contribute to delayed gastric emptying and appetite regulation, presenting a novel perspective in obesity research distinct from conventional GLP-1 agonists.